Stentys S.A.S. | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,393.60
3,851.00
6,102.00
7,318.00
7,036.00
8,873
Cost of Goods Sold (COGS) incl. D&A
2,277.00
2,711.00
3,557.00
5,211.00
4,242.00
6,642
Gross Income
1,116.50
1,140.00
2,545.00
2,107.00
2,794.00
2,231
SG&A Expense
13,645.50
15,706.00
12,631.00
9,570.00
8,590.00
8,545
EBIT
12,529.00
18,962.00
10,086.00
-
5,796.00
6,297
Unusual Expense
-
-
-
1,185.00
90.00
119
Non Operating Income/Expense
-
8.00
56.00
556.00
150.00
114
Interest Expense
138.10
88.00
213.00
29.00
60.00
116
Pretax Income
12,274.30
18,672.00
9,984.00
8,579.00
6,080.00
6,417
Income Tax
545.60
838.00
525.00
220.00
210.00
1,019
Consolidated Net Income
11,728.70
17,834.00
9,459.00
8,359.00
5,870.00
5,398
Net Income
11,728.70
17,834.00
9,459.00
8,359.00
5,870.00
5,398
Net Income After Extraordinaries
11,728.70
17,834.00
9,459.00
8,359.00
5,870.00
5,398
Net Income Available to Common
11,728.70
17,834.00
9,459.00
8,359.00
5,870.00
5,398
EPS (Basic)
0.91
1.38
0.69
0.46
0.33
0.22
Basic Shares Outstanding
12,897.40
13,002.90
13,720.00
18,147.10
19,424.60
25,010.40
EPS (Diluted)
0.91
1.15
0.59
0.42
0.30
0.22
Diluted Shares Outstanding
12,897.40
15,498.20
16,041.70
19,728.20
19,424.60
25,010.40
EBITDA
12,289.90
18,565.00
9,176.00
6,681.00
5,047.00
4,555
Other Operating Expense
-
4,396.00
-
491.00
-
17
Non-Operating Interest Income
392.70
370.00
259.00
33.00
16.00
1

About Stentys

View Profile
Address
18, rue d' Hauteville
Paris Ile-de-France 75010
France
Employees -
Website http://www.stentys.com
Updated 07/08/2019
Stentys SA engages in the design, development and marketing of self-expanding stents used in treating cardiovascular diseases. It provides innovative solutions to the interventional cardiologist to treat patients with acute myocardial infarction and other complex coronary disease. The company's products include xpositions, mistent, stentys btk, stentys ac, ses stent and stentys stent.